From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves 1st cell-based seasonal flu vaccine

from American Society of Health-System Pharmacists

The FDA recently announced the licensing of the nation's first seasonal influenza virus vaccine produced in a cell culture system instead of the traditional egg-based technology. Flucelvax, made by Novartis Vaccines, is an inactivated vaccine derived from virus propagated in a continuous cell line of canine kidney cell origin. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063